KR20010087421A - 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌 - Google Patents

4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌 Download PDF

Info

Publication number
KR20010087421A
KR20010087421A KR1020017007552A KR20017007552A KR20010087421A KR 20010087421 A KR20010087421 A KR 20010087421A KR 1020017007552 A KR1020017007552 A KR 1020017007552A KR 20017007552 A KR20017007552 A KR 20017007552A KR 20010087421 A KR20010087421 A KR 20010087421A
Authority
KR
South Korea
Prior art keywords
dihydro
methylene
methoxy
indol
lower alkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
KR1020017007552A
Other languages
English (en)
Korean (ko)
Inventor
룩킨-춘
마하니파이지이.
미슈케스티븐그레고리
Original Assignee
프리돌린 클라우스너, 롤란드 비. 보레르
에프. 호프만-라 로슈 아게
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 프리돌린 클라우스너, 롤란드 비. 보레르, 에프. 호프만-라 로슈 아게 filed Critical 프리돌린 클라우스너, 롤란드 비. 보레르
Publication of KR20010087421A publication Critical patent/KR20010087421A/ko
Ceased legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
    • C07D401/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing three or more hetero rings
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
    • C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
    • C07D403/14—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/14—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing three or more hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
    • C07D409/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing three or more hetero rings

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Rheumatology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Public Health (AREA)
  • Pain & Pain Management (AREA)
  • Immunology (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Indole Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
KR1020017007552A 1998-12-17 1999-12-07 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌 Ceased KR20010087421A (ko)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US11258998P 1998-12-17 1998-12-17
US60/112,589 1998-12-17
US14148299P 1999-06-29 1999-06-29
US60/141,482 1999-06-29
PCT/EP1999/009578 WO2000035906A2 (en) 1998-12-17 1999-12-07 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles

Publications (1)

Publication Number Publication Date
KR20010087421A true KR20010087421A (ko) 2001-09-15

Family

ID=26810125

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020017007552A Ceased KR20010087421A (ko) 1998-12-17 1999-12-07 4- 및 5-알키닐옥신돌과 4- 및 5-알케닐옥신돌

Country Status (14)

Country Link
EP (1) EP1149092B1 (cg-RX-API-DMAC7.html)
JP (1) JP2002532490A (cg-RX-API-DMAC7.html)
KR (1) KR20010087421A (cg-RX-API-DMAC7.html)
CN (1) CN1147486C (cg-RX-API-DMAC7.html)
AT (1) ATE253062T1 (cg-RX-API-DMAC7.html)
AU (1) AU771599B2 (cg-RX-API-DMAC7.html)
BR (1) BR9916272A (cg-RX-API-DMAC7.html)
CA (1) CA2354510A1 (cg-RX-API-DMAC7.html)
DE (1) DE69912479T2 (cg-RX-API-DMAC7.html)
DK (1) DK1149092T3 (cg-RX-API-DMAC7.html)
ES (1) ES2209527T3 (cg-RX-API-DMAC7.html)
PT (1) PT1149092E (cg-RX-API-DMAC7.html)
TR (1) TR200101747T2 (cg-RX-API-DMAC7.html)
WO (1) WO2000035906A2 (cg-RX-API-DMAC7.html)

Families Citing this family (28)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6569868B2 (en) 1998-04-16 2003-05-27 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity
MY128449A (en) 2000-05-24 2007-02-28 Sugen Inc Prodrugs of 3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives
JP2003535847A (ja) 2000-06-02 2003-12-02 スージェン・インコーポレーテッド 蛋白質キナーゼ/ホスファターゼ阻害剤としてのインドリノン誘導体
WO2002002551A1 (en) * 2000-06-30 2002-01-10 Sugen, Inc. 4-heteroaryl-3-heteroarylidenyl-2-indolinones and their use as protein kinase inhibitors
WO2002083648A1 (fr) 2001-04-16 2002-10-24 Eisai Co., Ltd. Nouveau compose a base de 1h-indazole
US7018999B2 (en) 2001-05-16 2006-03-28 Cephalon, Inc. Methods for the treatment and prevention of pain
WO2002096361A2 (en) 2001-05-30 2002-12-05 Sugen, Inc. 5-aralkylsulfonyl-3- (pyrrol-2-ylmethylidene)-2-indolinone derivatives as kinase inhibitors
WO2003010164A1 (en) 2001-07-23 2003-02-06 Applied Research Systems Ars Holding N.V. Arylsulfonamide derivatives as c-jun-n-terminal kinases (jnk's) inhibitors
MXPA04002537A (es) 2001-10-12 2004-05-31 Warner Lambert Co Alquinos como inhibidores de metaloproteinasa de matriz.
US6962922B2 (en) 2001-10-12 2005-11-08 Warner-Lambert Company Llc Alkynylated quinazoline compounds
US7390797B2 (en) 2002-02-28 2008-06-24 Eisai Co., Ltd. Fused indazole compounds
US6747147B2 (en) 2002-03-08 2004-06-08 Warner-Lambert Company Oxo-azabicyclic compounds
US6894057B2 (en) 2002-03-08 2005-05-17 Warner-Lambert Company Oxo-azabicyclic compounds
CN1656079A (zh) 2002-05-31 2005-08-17 卫材株式会社 吡唑化合物和含有该化合物的药物组合物
US7465736B2 (en) 2002-06-14 2008-12-16 Laboratoires Serono S.A. Azole methylidene cyanide derivatives and their use as protein kinase modulators
MXPA06004438A (es) 2003-10-24 2006-06-20 Schering Ag Derivados de indolinona y su uso en el tratamiento de enfermedades como el cancer.
DE102004012070A1 (de) * 2004-03-12 2005-09-29 Boehringer Ingelheim Pharma Gmbh & Co. Kg Neue cycloalkyl-haltige 5-Acylindolinone, deren Herstellung und deren Verwendung als Arzneimittel
US7803824B2 (en) 2004-10-29 2010-09-28 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases to treat glaucoma
US20060094753A1 (en) 2004-10-29 2006-05-04 Alcon, Inc. Use of inhibitors of Jun N-terminal kinases for the treatment of glaucomatous retinopathy and ocular diseases
WO2006090698A1 (ja) * 2005-02-22 2006-08-31 Ono Pharmaceutical Co., Ltd. キナーゼ阻害薬およびその用途
KR20080044836A (ko) 2005-07-15 2008-05-21 라보라뚜와르 세로노 에스. 에이. 자궁내막증 치료용 jnk 억제제
BRPI0613042A2 (pt) 2005-07-15 2010-12-14 Serono Lab inibidores de jnk para o tratamento de endometriose
CN1939922B (zh) * 2005-09-27 2010-10-13 天津和美生物技术有限公司 可抑制细胞释放肿瘤坏死因子的5H-噻吩[3,4-c]吡咯-4,6-二酮衍生物
WO2007040208A1 (ja) 2005-10-03 2007-04-12 Ono Pharmaceutical Co., Ltd. 含窒素複素環化合物およびその医薬用途
FR2962729B1 (fr) 2010-07-13 2012-09-21 Arkema France Molecules porteuses de groupes associatifs
FR2962733B1 (fr) 2010-07-13 2012-08-17 Michelin Soc Tech Polymere greffe par des molecules associatives azotees.
US20140205537A1 (en) * 2011-06-24 2014-07-24 Zenobia Therapeutics, Inc. Lrrk2 inhibitors
JP7270590B2 (ja) 2019-11-27 2023-05-10 財團法人工業技術研究院 自己発電式検出送信装置

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB9501567D0 (en) * 1995-01-26 1995-03-15 Pharmacia Spa Hydrosoluble 3-arylidene-2-oxindole derivatives as tyrosine kinase inhibitors
GB9507298D0 (en) * 1995-04-07 1995-05-31 Pharmacia Spa Substituted indolylmethylene-oxindale analogues as tyrosine kinase inhibitors
US5880141A (en) * 1995-06-07 1999-03-09 Sugen, Inc. Benzylidene-Z-indoline compounds for the treatment of disease
GB9610964D0 (en) * 1996-05-24 1996-07-31 Pharmacia & Upjohn Spa Substituted tetralylmethylen-oxindole analogues as tyrosine kinase inhibitors
EP0929520B1 (en) * 1996-08-23 2005-11-02 Sugen, Inc. Indolinone combinatorial libraries and related products and methods for the treatment of disease
CA2289102A1 (en) * 1997-05-07 1998-11-12 Sugen, Inc. 2-indolinone derivatives as modulators of protein kinase activity

Also Published As

Publication number Publication date
BR9916272A (pt) 2001-09-04
WO2000035906A3 (en) 2000-11-09
PT1149092E (pt) 2004-03-31
DE69912479T2 (de) 2004-07-22
CA2354510A1 (en) 2000-06-22
EP1149092B1 (en) 2003-10-29
ES2209527T3 (es) 2004-06-16
AU1507600A (en) 2000-07-03
WO2000035906A2 (en) 2000-06-22
CN1331689A (zh) 2002-01-16
DE69912479D1 (de) 2003-12-04
TR200101747T2 (tr) 2001-11-21
AU771599B2 (en) 2004-03-25
ATE253062T1 (de) 2003-11-15
JP2002532490A (ja) 2002-10-02
CN1147486C (zh) 2004-04-28
DK1149092T3 (da) 2004-02-23
EP1149092A2 (en) 2001-10-31

Similar Documents

Publication Publication Date Title
EP1149092B1 (en) 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
US6307056B1 (en) 4-aryloxindoles
KR100738165B1 (ko) 헤테로방향족 카르복사미드 유도체 및 ikk-2 효소억제제로서의 용도
KR100481757B1 (ko) Cdk2 억제제인 피라졸로벤조디아제핀
US5874427A (en) Substituted heteroaromatic 5-HT1F agonists
PL180027B1 (pl) Nowe zwiazki, skondensowane pirolokarboksyanilidy, bedace nowa klasa ligandów receptora mózgowego GABA PL PL PL PL PL PL PL PL
EP1444207A2 (en) Substituted pyrazolyl-compounds for the treatment of inflammation
US6221867B1 (en) 4,5-pyrazinoxindoles
US5792766A (en) Imidazo 1,5-c! quinazolines; a new class of GABA brain receptor ligands
KR20050098248A (ko) 효소 ikk-2의 저해제로서의 티오펜 카르복사미드
EP0126401A1 (de) Neue Indolverbindungen
US6313310B1 (en) 4-and 5-alkynyloxindoles and 4-and 5-alkenyloxindoles
AU777702B2 (en) Substituted 3-pyridyl-4-arylpyrroles, and related therapeutic and prophylactic methods
EP1501805A1 (en) Substituted pyrazolyl compounds for the treatment of inflammation
MXPA01006049A (en) 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles
KR100519831B1 (ko) 티에노피롤리디논
ZA200104281B (en) 4- and 5-alkynyloxindoles and 4- and 5-alkenyloxindoles.
MXPA01006141A (en) 4-aryloxindoles as inhibitors of jnk protein kinases
ZA200104320B (en) 4-Aryloxindoles as inhibitors of JNK protein kinases.
KR20010039263A (ko) 간 섬유화 억제작용을 나타내는 벤조[3,4-d]1,3-디옥솔란 유도체

Legal Events

Date Code Title Description
PA0105 International application

Patent event date: 20010615

Patent event code: PA01051R01D

Comment text: International Patent Application

PG1501 Laying open of application
A201 Request for examination
PA0201 Request for examination

Patent event code: PA02012R01D

Patent event date: 20041206

Comment text: Request for Examination of Application

E902 Notification of reason for refusal
PE0902 Notice of grounds for rejection

Comment text: Notification of reason for refusal

Patent event date: 20060418

Patent event code: PE09021S01D

E601 Decision to refuse application
PE0601 Decision on rejection of patent

Patent event date: 20060626

Comment text: Decision to Refuse Application

Patent event code: PE06012S01D

Patent event date: 20060418

Comment text: Notification of reason for refusal

Patent event code: PE06011S01I